July 9, 2000
However, in my opinion, he neglected to acknowledge that nothing is so simple -- that even with free drugs we will not be able tackle the problem and that the drug companies are not abstract institutions whose only goal is to make money. Drug companies are publicly traded companies. In fact, many of the medical professionals in the audience at this lecture have a vested interest in these companies. He also forgot to remind us that not a small percentage of our retirement and kids' college funds are invested in drug companies (whether directly or in mutual funds). He forgot to ask us how much of that we are willing to personally sacrifice to improve the situation in the developing world. He forgot to point out that perhaps as much as half of the medical professionals who are attending the AIDS conference from the developed world had their airplane trip to South Africa paid for by drug companies, not to mention that a significant portion of the research we do is linked and funded by them. So it is a complex issue, and although we Westerners are clearly not ready for deep analysis, he told us what we wanted to hear, which is at least part of the truth, and we all started the conference full of energy.